Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor-Reference-Cited by-同舟云学术

Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor

Published:2022 Issue: Volume:55 Page:
ISSN:1414-431X
Container-title:Brazilian Journal of Medical and Biological Research
language:
Short-container-title:Braz J Med Biol Res

Author:

Machado-Rugolo J.¹^ORCID,Baldavira C.M.²^ORCID,Prieto T.G.²^ORCID,Olivieri E.H.R.³^ORCID,Fabro A.T.⁴^ORCID,Rainho C.A.⁵^ORCID,Castelli E.C.⁶^ORCID,Ribolla P.E.M.⁶^ORCID,Ab'Saber A.M.²^ORCID,Takagaki T.²^ORCID,Nagai M.A.⁷^ORCID,Capelozzi V.L.²^ORCID

Affiliation:

1. Universidade de São Paulo, Brasil; Universidade Estadual Paulista, Brasil

2. Universidade de São Paulo, Brasil

3. AC Camargo Cancer Center, Brasil

4. Universidade de São Paulo, Brasil; Universidade de São Paulo, Brasil

5. Universidade Estadual Paulista, Brasil

6. Universidade Estadual Paulista, Brasil; Universidade Estadual Paulista, Brasil

7. Universidade de São Paulo, Brasil; Instituto do Câncer de São Paulo, Brasil

Publisher

FapUNIFESP (SciELO)

Subject

General Medicine,Cell Biology,General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Immunology,Physiology,Biochemistry,General Neuroscience,Biophysics

Link

http://www.scielo.br/scielo.php?script=sci_pdf&pid=S0100-879X2022000100687&tlng=en

Reference33 articles.

1. Lung cancer in Brazil: epidemiology and treatment challenges;de Sá VK;Lung Cancer (Auckl),2016

2. Lung cancer in Brazil;Araujo LH;J Bras Pneumol,2018

3. Impact of microvascular invasion on 5-year overall survival of resected non-small cell lung cancer;Monteiro AS;J Bras Pneumol,2022

4. Adjuvant chemotherapy for non-small cell lung cancer: practice patterns and outcomes in the general population of Ontario, Canada;Booth CM;J Thorac Oncol,2012

5. Deconstructing ADAURA: It is time to forgo adjuvant platinum-based chemotherapy in resected IB-IIIA EGFR+ NSCLC (except with RB alterations?) When adopting adjuvant osimertinib;Zhang SS;Lung Cancer (Auckl),2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antineoplastics;Reactions Weekly;2023-05-06